GlassScriptPhysician profile
Larry J Friedman
NPI 1770566895
$1,726.34
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $333 · 2020: $187 · 2021: $620 · 2022: $586.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $385.01 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $353.56 | 2019-2022 | |
| Novo Nordisk INC | $212.33 | 2019-2022 | |
| Abbvie INC. | $205.43 | 2021-2022 | |
| Lilly USA, LLC | $144.40 | 2019-2022 | |
| Glaxosmithkline, LLC. | $91.24 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $77.18 | 2019-2022 | |
| Pfizer INC. | $56.49 | 2020-2021 | |
| Esperion Therapeutics, INC. | $50.52 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $30.16 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $25.00 | 2020 | |
| Abbott Laboratories | $20.86 | 2020 | |
| Genentech USA, INC. | $19.74 | 2019 | |
| Daiichi Sankyo INC. | $18.61 | 2020 | |
| Novartis Pharmaceuticals Corporation | $18.14 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $17.67 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Friedman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.